. home.aspx

home.aspx
   

Pfizer Won’t Win the Coronavirus Pharma War

March 06, 2020

Shares of Pfizer  jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any positive news from the pharma community after the recent selloff. So, does this mean that Pfizer stock is turning the corner?